Company intelligence / Profile preview

NeuroLyze

Boston, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

NeuroLyze is an early-stage health technology startup developing a smart wearable device designed to be inserted into athletic helmets to monitor head impacts in real-time. Founded by students from the University of Massachusetts Lowell, the company's technology detects and quantifies the magnitude of impacts athletes endure during contact sports. By continuously tracking trauma-related parameters and alerting users when safe thresholds are exceeded, NeuroLyze aims to prevent long-term brain damage and conditions like Chronic Traumatic Encephalopathy (CTE). The startup is currently refining its minimum viable product (MVP) and building its data platform for beta testing.

Therapeutic areas: Neurology
Modalities: Device
Industry: Physiological Monitoring

Beyond the preview

Go deeper on NeuroLyze.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NeuroLyze.

Explore the full profile